The World Anti-Doping Agency (WADA) has now reviewed the International Tennis Federation (ITF) Independent Tribunal's decision in the Maria Sharapova case. The Tribunal found that Maria Sharapova committed an Anti-Doping Rule Violation (ADRV) for the use of banned substance Meldonium, and that, as a consequence, a period of ineligibility of two (2) years was imposed, commencing on 26 January 2016.
After reviewing the decision in full, including the reasoning that led to the Tribunal’s decision, WADA today confirms that it will not be exercising its independent right of appeal to the Court of Arbitration for Sport (CAS).
We acknowledge that Ms. Sharapova has today lodged her own appeal to CAS. The ITF will be the respondent in the appeal. As with all cases, and in order to respect the integrity of the legal process, WADA will refrain from commenting on the case until a decision has been rendered by CAS.